Crawford, E., Sutton, S. S., Moul, J. W., Pettaway, C. A., Hardin, J. W., Poston, S. A., & Kruep, E. J. (2010). Using prostate-specific antigen threshold to identify increased 4-year risk of prostate cancer. In Journal of Clinical Oncology (Vol. 28, pp. 4565–4565). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2010.28.15_suppl.4565

Crawford, E., S. S. Sutton, J. W. Moul, C. A. Pettaway, J. W. Hardin, S. A. Poston, and E. J. Kruep. “Using prostate-specific antigen threshold to identify increased 4-year risk of prostate cancer.” In Journal of Clinical Oncology, 28:4565–4565. American Society of Clinical Oncology (ASCO), 2010. https://doi.org/10.1200/jco.2010.28.15_suppl.4565.

Crawford E, Sutton SS, Moul JW, Pettaway CA, Hardin JW, Poston SA, et al. Using prostate-specific antigen threshold to identify increased 4-year risk of prostate cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. 4565–4565.

Crawford, E., et al. “Using prostate-specific antigen threshold to identify increased 4-year risk of prostate cancer.” Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2010, pp. 4565–4565. Crossref, doi:10.1200/jco.2010.28.15_suppl.4565.

Crawford E, Sutton SS, Moul JW, Pettaway CA, Hardin JW, Poston SA, Kruep EJ. Using prostate-specific antigen threshold to identify increased 4-year risk of prostate cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. 4565–4565.